THE FAUCI FILES, Vol 3(1): Anthrax Vaccine Scandal Unravels, Part I
January 3, 2000
Joint Chiefs of Staff Ex-Chairman Admiral Crowe Owns Vaccine Company
In the FDA action involving BioPort, the military?s anthrax
vaccine plans grind to a halt, as suggestions of yet another
obnoxious government ethics scandal have become all too familiar:
?One of the owners of BioPort is Adm. William Crowe, the
retired chairman of the Joint Chiefs of Staff.?
?The Pentagon ... has put a brigadier general in charge of
making sure the privately owned company gets its plant
approved quickly?
?BioPort bought the lab from Michigan Biologic Products
Institute for $25 million in 1998, and in the face of
bankruptcy, tripled the price of the anthrax vaccine in
August, with the Pentagon?s approval. The Defense
Department awarded the company an additional $18.7 million
for the vaccines it had already purchased.?
?The Pentagon is giving BioPort of Lansing, Mich.,
$7 million to $10 million, on top of the $130 million
it already invested...?
No explanation is offered for the BioPort ownership ?interests?
of Admiral Crowe. However, the human experiment continues, even
though the Anthrax vaccine remains UNAPPROVED by the FDA:
?Two years ago, the department (of Defense) began
vaccinating soldiers who were being deployed to so-called
high-threat areas...?
?The military needs about 75,000 doses a month to inoculate
soldiers...?
The Anthrax vaccine for the U.S. military has been rather
controversial since early 1999. While the actual reasons
for the controversy have not been made clear, it seems
that media has simply focused on the soldiers who have refused
their commanding officers? orders to be vaccinated against
Anthrax in full knowledge that they would be court-martialed.
In another recent report on this subject, the military denied
the Anthrax vaccine could cause health problems, yet the
military doctors admitted that they had NOT been monitoring the
potential for health problems that could result from the
Anthrax vaccine.
>From the UPI article of December 13, 1999 (below), here are some
revealing quotes:
?The Defense Department had hoped to begin inoculating
soldiers early next year, said Dr. Sue Bailey, assistant
secretary of defense for health affairs.?
?Another million doses, dating as far back as 1985, are
warehoused but have not been certified for use for various
reasons?
?Various reasons?? Hmmm, one must wonder what exact
contaminants are in those warehoused vaccines, who was harmed
by them, and who in the government got rich from yet another
scam that endangers the lives of military "lab rats"?
Naturally, since NIH/NIAID?s Dr. Anthony ?Mussolini? Fauci,
M.D. remains the Direktor of the government agency in charge of
vaccines and since Fauci is NO STRANGER to these sort of
scandals, one must wonder about the extent of Fauci?s
involvement in the Anthrax vaccine scam [NOTE: Fauci?s own
murderous IL-2 patent scandal as a possible ?HIV cure? lasted a
decade, squandered millions in tax dollars and killed
thousands. More recently, Fauci?s patent-pending ?invention? of HIV
vaccine peptides were shown to INCREASE the risk of HIV
infection for the vaccinated, rather than prevent infection].
While the military claims that its ?need? for the vaccine is an
urgent one, yet it does not appear to be in a rush to find an
alternate supplier, nor does it seem to be interested in using
the vaccines that have been in storage since 1986.
Apparently, the crooks in the Defense Department have granted
Admiral Crowe?s vaccine an exclusive -- it will be the Admiral's
vaccine, or it will be no vaccine.
And the best of the worst is yet to come ... so stay tuned
for Part II !!!
Crooked Murdering Bastards!
fred
====================================
Anthrax Vaccine Maker Fails FDA test
WASHINGTON, Dec. 13 (UPI) -- The Pentagon?s only producer of
the anthrax vaccine failed its FDA inspection last month,
impeding the Defense Department?s ability to inoculate soldiers
if a conflict of the scope of the Persian Gulf War started,
according to Pentagon officials.
?We could not today do a full blow-up to (a Desert Storm-size
conflict) and have every serviceman or woman vaccinated on the
battlefield,? said Maj. Gen. Randall West, the Pentagon?s
special adviser on anthrax and biological defense matters.
Desert Storm required the deployment of more than 500,000
soldiers.
The Defense Department had hoped to begin inoculating soldiers
early next year, said Dr. Sue Bailey, assistant secretary of
defense for health affairs.
The Pentagon is giving BioPort of Lansing, Mich., $7 million to
$10 million, on top of the $130 million it already invested, to
help correct the problem and has put a brigadier general in
charge of making sure the privately owned company gets its
plant approved quickly, said David Oliver, principal deputy
undersecretary of defense for acquisition.
One of the owners of BioPort is Adm. William Crowe, the retired
chairman of the Joint Chiefs of Staff. The plant was hit with
34 equipment and process-related deficiencies by Food and Drug
Administration inspectors in November, setting back the
Pentagon?s hoped-for mass vaccination program by six to 12
months, said Oliver. There will be a series of follow-up
inspections that could reveal more problems, Oliver said.
There is no deadline for attaining certification, Oliver
explained, because the Defense Department?s foremost concern is
that the vaccine be both safe and effective.
Two years ago, the department began vaccinating soldiers who
were being deployed to so-called high-threat areas: the Persian
Gulf and South Korea, areas where anthrax spores are believed
to be packed in weapons by Iraq and North Korea. At any given
time, there are roughly 23,000 service personnel in the Gulf
and 37,000 in Korea.
The military needs about 75,000 doses a month to inoculate
soldiers deployed to those regions, and those preparing to
deploy.
About 383,000 military personnel have received the six-course
vaccination so far. The Pentagon had hoped to begin the second
phase of its operation, which involves having enough vaccine on
hand to immunize hundreds of thousands of soldiers rapidly in
the event of a major crisis.
As it stands, the department has about 2 million usable doses?
just enough to continue immunizing soldiers who rotate in and
out of the Gulf and Korea until BioPort is expected to produce
viable, safe vaccine.
The Pentagon is funding BioPort to the tune of about $130
million to build a state-of-the-art production facility on the
site of an old Michigan state-run laboratory and expects to
spend $228 million on the program between fiscal years 2001 and
2005. Production will burgeon from the old rate of about 2,000
doses a year to 400,000 a month.
Another million doses, dating as far back as 1985, are
warehoused but have not been certified for use for various
reasons, Oliver said.
BioPort bought the lab from Michigan Biologic Products
Institute for $25 million in 1998, and in the face of
bankruptcy, tripled the price of the anthrax vaccine in August,
with the Pentagon?s approval. The Defense Department awarded
the company an additional $18.7 million for the vaccines it had
already purchased.
Oliver said he thinks the company will rise to the challenge of
fixing the new lab?s faults and producing the vaccine in
sufficient amounts. He said he believes this ?because the
people are inherently good people.?
Bailey said the vaccine is the best method of protecting
soldiers from anthrax, although protective clothing and
antibiotics are also available.
----------
